Journal rankings · indicator year 2010
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Field ranking · 2010
Immunology and Microbiology journal rankings 2010
100 ranked journals · Field in Life Sciences
Immunology and Microbiology has 100 ranked journals in 2010. Its median journal scores above the world average: OJR 1.11 against 1.00, down 0.04 on 2009. A journal needs OJR 1.52 to reach Q1. The top three are Nature Immunology, Immunity, and The Journal of Experimental Medicine.
Ranks and citation indicators: 2010. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2007–2009, the window the 2010 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields in Immunology and Microbiology (5)
Up to Life Sciences100 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2009. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2007–2009, the window the 2010 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2007–2009 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2001 to 2010. | Compare |
|---|---|---|---|---|---|---|---|
1Nature ImmunologyNature Portfolio · United States | 6.19Q1 | 18.20 1.01 up from 2009 | 682 | 56% | $12,690 | ||
2ImmunityCell Press · United States | 6.18Q1 | 19.60 2.21 up from 2009 | 626 | 100% | $10,400 | ||
3The Journal of Experimental MedicineRockefeller University Press · United States | 4.49Q1 | 12.31 0.30 down from 2009 | 1,113 | 87% | — | ||
4Seminars in ImmunologyElsevier BV · United States | 3.35Q1 | 8.65 1.63 down from 2009 | 151 | 51% | $4,370 | ||
5Annual Review of ImmunologyAnnual Reviews · United States | 3.06Q1 | 57.98 20.68 up from 2009 | 70 | 41% | — | ||
6Seminars in ImmunopathologySpringer Science+Business Media · Germany | 2.84Q1 | 7.18 1.08 up from 2009 | 116 | 48% | $3,790 | ||
7Journal of Allergy and Clinical ImmunologyElsevier BV · United States | 2.83Q1 | 7.85 0.17 up from 2009 | 1,460 | 51% | $4,900 | ||
8The AAPS JournalSpringer Science+Business Media · United States | 2.53Q1 | 4.11 0.40 down from 2009 | 213 | 98% | $5,090 | ||
9Mucosal ImmunologyOAElsevier BV · United States | 2.51Q1 | 6.13 1.93 up from 2009 | 164 | 100% | $4,370 | ||
10Journal of AutoimmunityElsevier BV · United Kingdom | 2.41Q1 | 7.72 0.14 up from 2009 | 288 | 37% | $5,420 | ||
11International Journal for ParasitologyElsevier BV · Australia | 2.08Q1 | 3.74 0.04 down from 2009 | 523 | 26% | $2,880 | ||
12The Journal of ImmunologyAmerican Association of Immunologists · United States | 2.08Q1 | 6.31 0.06 up from 2009 | 6,009 | 37% | $3,500 | ||
13Infection and ImmunityOAAmerican Society for Microbiology · United States | 2.05Q1 | 4.52 0.07 down from 2009 | 1,925 | 100% | — | ||
14Genes and ImmunitySpringer Nature · United States | 1.89Q1 | 4.90 0.04 up from 2009 | 291 | 51% | $3,190 | ||
15Nature reviews. ImmunologyNature Portfolio · United Kingdom | 1.87Q1 | 15.36 0.51 up from 2009 | 625 | 16% | — | ||
16BioDrugsAdis, Springer Healthcare · Switzerland | 1.83Q1 | 5.32 1.18 up from 2009 | 119 | 8% | $5,190 | ||
17Sexually Transmitted InfectionsBMJ · United Kingdom | 1.78Q1 | 3.57 0.70 up from 2009 | 447 | 55% | — | ||
18Journal of Leukocyte BiologyOxford University Press · United States | 1.71Q1 | 4.89 0.49 up from 2009 | 962 | 34% | $3,800 | ||
19Molecular and Biochemical ParasitologyElsevier BV · Netherlands | 1.63Q1 | 3.16 0.09 up from 2009 | 411 | 51% | $3,460 | ||
20European Journal of ImmunologyWiley · Germany | 1.60Q1 | 4.70 0.32 down from 2009 | 1,206 | 72% | $4,550 | ||
21Vector-Borne and Zoonotic DiseasesMary Ann Liebert, Inc. · United States | 1.60Q1 | 3.06 0.02 down from 2009 | 348 | 22% | — | ||
22Sexually Transmitted DiseasesLippincott Williams & Wilkins · United States | 1.60Q1 | 3.15 0.48 up from 2009 | 529 | 27% | — | ||
23Clinical and Developmental ImmunologyOAHindawi Publishing Corporation · United Kingdom | 1.54Q1 | 3.03 1.20 down from 2009 | 49 | 100% | $2,100 | ||
24ImmunobiologyOAElsevier BV · Germany | 1.52Q1 | 3.84 0.05 up from 2009 | 304 | 29% | $2,840 | ||
25Clinical ImmunologyElsevier BV · Netherlands | 1.52Q1 | 4.08 0.12 up from 2009 | 564 | 9% | $4,400 | ||
26Immunity & AgeingOABioMed Central · United Kingdom | 1.51Q2 | 3.69 0.03 down from 2009 | 38 | 100% | $3,190 | ||
27BMC ImmunologyOABioMed Central · United Kingdom | 1.50Q2 | 3.68 0.30 up from 2009 | 170 | 100% | $3,090 | ||
28Expert Opinion on Biological TherapyTaylor & Francis · United Kingdom | 1.49Q2 | 4.06 0.38 up from 2009 | 473 | 18% | — | ||
29Critical Reviews in ImmunologyBegell House · United States | 1.48Q2 | 4.36 0.86 up from 2009 | 81 | 26% | — | ||
30Journal of Clinical ImmunologySpringer Science+Business Media · United States | 1.48Q2 | 3.72 0.09 down from 2009 | 283 | 39% | $4,990 | ||
31Clinical Reviews in Allergy & ImmunologySpringer Nature · United States | 1.45Q2 | 3.25 0.07 up from 2009 | 234 | 21% | $5,490 | ||
32International ImmunologyOxford University Press · United Kingdom | 1.44Q2 | 3.84 0.14 up from 2009 | 422 | 27% | $3,530 | ||
33CytokineElsevier BV · United Kingdom | 1.43Q2 | 3.72 0.06 down from 2009 | 522 | 7% | $3,220 | ||
34International Reviews of ImmunologyTaylor & Francis · United States | 1.40Q2 | 4.42 1.08 up from 2009 | 61 | 19% | — | ||
35Parasites & VectorsOABioMed Central · United Kingdom | 1.38Q2 | 2.44 0.35 down from 2009 | 109 | 100% | $3,090 | ||
36Experimental and Applied AcarologySpringer Science+Business Media | 1.36Q2 | 1.92 0.11 down from 2009 | 287 | 26% | $2,390 | ||
37Toxicologic PathologySAGE Publishing · United States | 1.33Q2 | 2.58 0.14 down from 2009 | 354 | 45% | $4,150 | ||
38Inflammation & Allergy - Drug TargetsBentham Science Publishers · Netherlands | 1.33Q2 | 3.65 0.51 up from 2009 | 92 | 2% | — | ||
39Parasite ImmunologyWiley · United Kingdom | 1.31Q2 | 2.32 0.24 up from 2009 | 261 | 24% | $4,220 | ||
40Comparative Immunology Microbiology and Infectious DiseasesElsevier BV · United Kingdom | 1.30Q2 | 2.33 0.39 down from 2009 | 156 | 7% | $3,550 | ||
41Immunologic ResearchSpringer Science+Business Media · United States | 1.23Q2 | 3.95 1.37 up from 2009 | 217 | 68% | $2,890 | ||
42Clinical & Experimental ImmunologyOxford University Press · United Kingdom | 1.22Q2 | 3.62 0.22 up from 2009 | 784 | 93% | $3,816 | ||
43Innate ImmunityOASAGE Publishing · United Kingdom | 1.20Q2 | 2.82 0.12 down from 2009 | 97 | 35% | $2,650 | ||
44ImmunologyWiley · United Kingdom | 1.18Q2 | 3.48 0.49 up from 2009 | 675 | 75% | $5,330 | ||
45Developmental & Comparative ImmunologyElsevier BV · United Kingdom | 1.16Q2 | 3.52 0.35 up from 2009 | 395 | 17% | $3,340 | ||
46Zoonoses and Public HealthWiley · Germany | 1.15Q2 | 2.11 0.16 up from 2009 | 300 | 23% | $4,880 | ||
47Immunology and Cell BiologyWiley · Australia | 1.15Q2 | 3.05 0.46 down from 2009 | 346 | 39% | $3,750 | ||
48Molecular ImmunologyElsevier BV · Netherlands | 1.15Q2 | 3.13 0.24 down from 2009 | 1,146 | 13% | $3,340 | ||
49Experimental ParasitologyElsevier BV · United States | 1.15Q2 | 2.33 0.36 up from 2009 | 615 | 27% | $3,470 | ||
50Journal of Endotoxin ResearchManey Publishing · United Kingdom | 1.12Q2 | 0.00 3.11 down from 2009 | 38 | — | — |
Subfields of Immunology and Microbiology, compared.
Journals
Citations made in 2010. Corpus-wide, 73.2% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
34 additional Immunology and Microbiology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2007–2009, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2010. Publication window: 2007–2009. How these summaries are calculated
- Ranked journals
- 100
- Window papers (baseline)
- 103,748 +21.8% from indicator year 2007
- Median OJR
- 1.11 +17.3% from indicator year 2007
- Rising journals (2025)
- 12Comparison-group list (12)
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2007–2009 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 77 | 81 | 84 | 87 | 84 | 88 | 92 | 96 | 96 | 99 | 100 | 109 | 113 | 118 | 117 | 124 | 126 | 135 | 135 | 131 | 134 | 128 | 131 | 132 | 133 | 130 | |
| Window papers (baseline) | 57,420 | 61,729 | 64,988 | 68,564 | 70,081 | 74,504 | 79,076 | 85,172 | 89,884 | 96,132 | 103,748 | 109,236 | 113,003 | 114,572 | 119,036 | 122,584 | 124,030 | 123,505 | 122,958 | 123,895 | 126,939 | 132,755 | 139,280 | 143,532 | 145,253 | 146,708 | |
| Median OJR | 0.70 | 0.78 | 0.80 | 0.76 | 0.79 | 0.837 | 0.88 | 0.945 | 0.98 | 1.15 | 1.11 | 1.089 | 1.07 | 1.04 | 1.052 | 1.053 | 1.092 | 0.99 | 0.954 | 0.948 | 0.89 | 0.847 | 0.841 | 0.854 | 0.87 | 0.853 |
| Measure | Category statistic | Eligible population |
|---|---|---|
| Journal self-citation share | Median: 1.9% | 116 journals |
| Retracted papers per 1,000 | Pooled rate: 1.118 per 1,000 | 102 journals |
| Output growth | Median: -14.5% | 121 journals |
| Open access share | Median: 82.5% | 130 journals |
| Listed APC (USD) | Median including $0 listed prices: $3,340 | 99 ranked journals with a known listed price, including $0 listed prices |
| International collaboration share | Median: 25.3% | 128 journals |
| Review share | Median: 1.1% | 130 journals |
| Articles-only OJR | Median: 0.85 | 125 journals |
| Uncited share | Median: 25.6% | 130 journals |
| Citation concentration | Median: 42.4% | 130 journals |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.